Strattera is indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) as part of a comprehensive treatment plan that includes psychological, social, and other interventions. This medication can improve attention span, concentration, and focus, while also reducing restlessness. Its mechanism of action is thought to involve restoring balance among specific neurotransmitters in the brain. Wellbutrin is a drug prescribed for the management of major depressive disorder (MDD) and seasonal affective disorder by influencing the neurotransmitters norepinephrine and dopamine in the brain and nerves. Wellbutrin XL is specifically for MDD and seasonal affective disorder, whereas Wellbutrin SR is solely for MDD. Zyban, another form of bupropion, is utilized to assist in smoking cessation, but Wellbutrin is not designed for this purpose.
https://medixway.com/strattera-vs-wellbutrin/

